HSBC on Aurobindo Pharma
Buy, TP Rs 1900
Lannett (Aurobindo’s subsidiary) launched generic version of Advair Diskus, its first inhalation product in US
Significant launch for Aurobindo in view of sizeable addressable market size & limited competition
addressable market for Advair Diskus (including its generic equivalents) in US is over USD650m, per co
There are currently five approved generics for Advair Diskus – Viatris, Hikma, Teva, Lannett and Cipla.
Viatris, Hikma, Teva generics are in market
There is authorized generic (AG) in market also, launched by Prasco.
Viatris is currently leading in terms of prescription market share
4September 2, 2026 1.1K 1
